A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent. (4th November 2015)

Record Type:
Journal Article
Title:
A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent. (4th November 2015)
Main Title:
A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent
Authors:
Sharma, Padmanee
Grimm, Marc-Oliver
Galsky, Matthew D
Baron, Ari
Bracarda, Sergio
Siefker-Radtke, Arlene
Lambert, Alexandre
Azrilevich, Alex
Retz, Margitta
Abstract:
Is Part Of:
Journal for immunotherapy of cancer. Volume 3(2015)Supplement 2
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Issue Display:
Volume 3, Issue 2 (2015)
Year:
2015
Volume:
3
Issue:
2
Issue Sort Value:
2015-0003-0002-0000
Page Start:
Page End:
Publication Date:
2015-11-04
Subjects:
Bladder Cancer -- Ipilimumab -- Immune Checkpoint -- Urothelial Cancer -- Immune Checkpoint Inhibitor
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:
http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:
10.1186/2051-1426-3-S2-P174 ↗
Languages:
English
ISSNs:
2051-1426
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
19195.xml